Medical News

RSS

TAXUS Element Stent has comparable levels of TLR and late loss in diabetic and non-diabetic patients

Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.

23 Sep 2010

Infinity Pharmaceuticals to present IPI-926 inhibitor Phase 1 data at ESMO Congress

Infinity Pharmaceuticals, Inc. today announced that Phase 1 data of its novel Hedgehog pathway inhibitor, IPI-926, will be presented during the 35th Congress of the European Society of Molecular Oncology (ESMO), in Milan, Italy.

23 Sep 2010

A guide to Sept. 23: Health law's big day

Kaiser Health News has gathered a collection of resources to coincide with Sept. 23 -- health reform's big day.

23 Sep 2010

Hyponatremia may lead to neurological complications

A new study published in the October issue of the journal Hepatology found that patients with severe portal-hypertensive bleeding who are treated with terlipressin may experience an acute reduction of sodium in their blood. This reduction in serum sodium, known as hyponatremia, can cause adverse reactions such as neurological complications, and is rapidly reversible upon terlipressin withdrawal.

23 Sep 2010

FDA grants priority review status for Endo’s oxymorphone oral formulation

Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.

23 Sep 2010

Scientists create human liver cells using stem cells

Emerging Healthcare Solutions President and CEO Cindy Morrissey said Tuesday that a recent study at the University of Cambridge seems to indicate that realistic stem cell therapies to replace diseased or damaged tissues may be closer than ever.

23 Sep 2010

Beta-Pro donates human pancreatic islet cells to diabetes researcher

The cellular services company Beta-Pro LLC, announced today that it donated more than 300,000 human pancreatic islet cells to nationally renowned diabetes researcher Raghavendra G. Mirmira, M.D., Ph.D., the Eli Lilly & Co. Professor of Pediatric Diabetes, Indiana University School of Medicine, Herman B.

23 Sep 2010

Diagenode releases two monoclonal antibodies to enrich 5-hmC epigenetics research

Diagenode announced today that it has released two additional 5-hmC antibodies to complement its original 5-hmC (rat) monoclonal antibody. The two new 5-hmC monoclonal antibody (mouse) and polyclonal antibody (rabbit) antibodies give researchers additional choices for enriching and analyzing 5-hmC in their methylation studies.

23 Sep 2010

Americans head south to Mexico for cheaper health care

Americans are flocking to Mexico for discount health care, The San Francisco Chronicle reports.

23 Sep 2010

NanoViricides enters agreement with Seaside to purchase Series B Convertible Preferred Stock

NanoViricides, Inc., announced today that it had reached an agreement with Seaside 88, LP a Florida limited partnership, for the exercise of Seaside's option to purchase an additional $2.5M of the Company's Series B Convertible Preferred Stock.

23 Sep 2010

BARDA awards Rapid Micro Biosystems $6.7M contract to develop rapid sterility testing platform for vaccines

Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, today announced that it has signed a contract with the Biomedical Advanced Research and Development Authority (BARDA) for the development of rapid sterility testing for vaccines as part of the Innovative Platform Technologies program of BARDA's Strategic Science and Technology Division.

23 Sep 2010

U.S. joins whistleblower suit against Pfizer for drug marketing

The Wall Street Journal: "The Justice Department is trying to take the lead in a lawsuit accusing Pfizer Inc.'s Wyeth unit of improperly promoting an organ-transplant drug for unauthorized uses and paying illegal kickbacks to doctors. The lawsuit was filed by two former Wyeth sales representatives who were responsible for promoting Rapamune, an immunosuppressant used to prevent the body's rejection of transplanted kidneys.

23 Sep 2010

AstraZeneca to use THEW database for cardiac safety evaluation

AstraZeneca purchased a one-year membership to gain access to an international repository of data designed to aid industry and academic researchers developing new technologies to improve cardiac safety.

23 Sep 2010

Weight-based taribavirin reduces anemia, increases sustained virologic response

Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).

23 Sep 2010

Intarcia Therapeutics presents ITCA 650 phase 2 study results for type 2 diabetes

Intarcia Therapeutics, Inc. presented today final results of a 24-week phase 2 clinical study of ITCA 650 (DUROS continuous subcutaneous delivery of exenatide) for the treatment of type 2 diabetes at the 46th Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden.

23 Sep 2010

Mother’s miracle surgery for cancer - body cut in half

Janis Ollson, 31 became the first patient to survive a rare bone cancer which required her body to be cut in half. When she was pregnant with her second child doctors assumed her intense back pain was just a typical symptom of pregnancy. But soon she was diagnosed with a bone cancer called sarcoma that was untreatable by chemotherapy or radiation.

23 Sep 2010

Anthera Pharmaceuticals closes financing transaction

Anthera Pharmaceuticals, Inc., today announced that it has entered into definitive agreements with certain accredited investors in connection with a private placement, or PIPE, financing transaction pursuant to Section 4(2) of the Securities Act of 1933, as amended, and Regulation D promulgated thereunder.

23 Sep 2010

Tobacco taxes help kick the habit

The hike in Australia’s tobacco tax has had an expected effect with almost 300,000 people quitting the habit. The tax increase arrived this April with a 25% rise in tobacco taxes. Polls now confirm that the cost of cigarettes are a powerful lever for improving public health, with only 16 per cent of smokers stating they would “continue to smoke at any price”.

23 Sep 2010

Today's Opinions: Coloradans' insurance concerns, contraception and New York's Medicaid burden

For years, Coloradans have lived with uncertainty about their health insurance: lifetime caps, recisions, coverage for life-saving screenings. New provisions that begin Thursday, the six-month anniversary of the signing of the Affordable Care Act, address some of the biggest concerns consumers had about the failing health system (Dede de Percin, 9/22).

23 Sep 2010

Boston announces TAXUS ATLAS clinical trial data for complex lesions

Boston Scientific Corporation today announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberte Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.

23 Sep 2010

Medical News

TAXUS Element Stent has comparable levels of TLR and late loss in diabetic and non-diabetic patients

Infinity Pharmaceuticals to present IPI-926 inhibitor Phase 1 data at ESMO Congress

A guide to Sept. 23: Health law's big day

Hyponatremia may lead to neurological complications

FDA grants priority review status for Endo’s oxymorphone oral formulation

Scientists create human liver cells using stem cells

Beta-Pro donates human pancreatic islet cells to diabetes researcher

Diagenode releases two monoclonal antibodies to enrich 5-hmC epigenetics research

Americans head south to Mexico for cheaper health care

NanoViricides enters agreement with Seaside to purchase Series B Convertible Preferred Stock

BARDA awards Rapid Micro Biosystems $6.7M contract to develop rapid sterility testing platform for vaccines

U.S. joins whistleblower suit against Pfizer for drug marketing

AstraZeneca to use THEW database for cardiac safety evaluation

Weight-based taribavirin reduces anemia, increases sustained virologic response

Intarcia Therapeutics presents ITCA 650 phase 2 study results for type 2 diabetes

Mother’s miracle surgery for cancer - body cut in half

Anthera Pharmaceuticals closes financing transaction

Tobacco taxes help kick the habit

Today's Opinions: Coloradans' insurance concerns, contraception and New York's Medicaid burden

Boston announces TAXUS ATLAS clinical trial data for complex lesions

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News